胸腺基质淋巴细胞生成素
特应性皮炎
医学
哮喘
前列腺素D2
过敏
免疫学
恶化
皮肤屏障
过敏性
皮肤病科
内科学
前列腺素
作者
Jessica Hui,Elena Goleva,Donald Y.M. Leung,Byung Eui Kim
标识
DOI:10.1016/j.anai.2023.08.007
摘要
Climate change is a global threat to public health and causes/worsens various diseases including atopic dermatitis (AD), allergic, infectious, cardiovascular diseases, physical injuries and mental disorders. The incidence of allergy, such as AD, has increased over the last several decades, and environmental factors such as climate change have been implicated as a potential mechanism. A significant amount of literature has been published on the impact of climate factors, including cold and hot temperature, on the skin barrier and AD. Studies in several countries have shown a greater incidence of AD in children born in the colder seasons of fall and winter. The effect of cold and warm temperature on itch, skin flares, increased outpatient visits, skin barrier dysfunction, development of AD, and asthma exacerbations have been reported. Understanding mechanisms by which changes in temperature influence allergies is critical to the development of measures for prevention and treatment of allergic disorders, such as AD and asthma. Low and high temperature induce production of proinflammatory cytokines and lipid mediators such as IL-1beta, thymic stromal lymphopoietin (TSLP), and prostaglandin E2, and cause itch and flares by activation of transient receptor potential vanilloid channels (TRPVs) such as TRPV1, TRPV3, and TRPV4. TRPV antagonists may attenuate temperature-mediated itch, skin barrier dysfunction, and exacerbation of AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI